Company News
Biocon Secures Yesintek Biosimilar in Nine Markets
Biocon signed a license agreement with Janssen Sciences Ireland for commercialization of its proposed biosimilar Yesintek™.
The agreement grants immediate market entry rights in Australia, Brazil, Chi
